Cellectis Market Cap

Cellectis has a market cap or net worth of €239.40 million as of March 6, 2026. Its market cap has increased by 129.45% in one year.

Market Cap

239.40M

Enterprise Value

270.60M

Revenue

70.36M

Ranking

n/a

PE Ratio

n/a

Stock Price

€3.23

Market Cap Chart

Since February 7, 2007, Cellectis's market cap has increased from 100.59M to 239.40M, an increase of 137.98%. That is a compound annual growth rate of 4.65%.

Market Cap History

Date	Market Cap	% Change
Mar 5, 2026	239.40M	-21.10%
Dec 31, 2025	303.40M	158.68%
Dec 31, 2024	117.29M	-40.86%
Dec 29, 2023	198.32M	118.98%
Dec 30, 2022	90.57M	-73.23%
Dec 31, 2021	338.35M	-67.37%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Transgene	245.35M
Genfit	442.68M
Innate Pharma	134.59M
MaaT Pharma	133.98M
Adocia	130.10M
Sensorion	119.54M
ABIONYX Pharma	118.89M
OSE Immunotherapeutics	95.29M

Market Cap Rankings